Miyazaki, K., Grover, N., Thomas, C., Tiger, Y. K., Pelcovits, A., Cortese, M., Davis, J., Kidwell, A., Moyo, T., Fitzgerald, L., Cohen, J., Melody, M., Kenkre, V., Herr, M., Ollila, T., Shouse, G., Antonio, D., Stephens, D., Shah, N., Nassour, N., Elghawy, O., Moreira, J., Dharia, A., Mubeen, S., Ma, S., Winter, J., Gordon, L., Hess, B., Epperla, N., Karmali, R. (2025). Bispecific antibody vs non-bispecific antibody systemic therapy as immediate next line treatment after chimeric antigen receptor T-cell (CART) failure in large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-4502